• Info
    • INFORMATION
    • Documentation
    • Tutorial
      • General introduction
      • Tutorial
      • Workshop materials
      • Workshop manual (PDF)
      • Workshop manual (Word)
      • Workshop videos
    • FOR DEVELOPERS
    • Linking to GPCRdb
    • Web services
  • GPCRdb
    • Citing GPCRdb
    • Receptor page
    • Data Mapper
    • SEQUENCES
    • Sequence alignments
    • Generic residue number tables
    • Generic variants
    • Isoforms
    • SEQUENCE ANALYSIS
    • Receptor similarity
      • BLAST (GPCRdb alignment)
      • BLAST (non-GPCRdb query)
      • Phylogenetic trees
      • Similarity matrix (all-to-all)
    • Site search (by seq. motif)
    • STRUCTURES
    • Structure coverage
    • Structures
    • Structure models (receptor)
    • Structure models (ligand complexes)
    • STRUCTURE ANALYSIS
    • Structure comparison tool
    • Structure similarity trees
    • Structure superposition
    • Generic residue numbering (PDB)    
    • Structure similarity search
    • STRUCTURE CONSTRUCTS
    • Construct/Experiment design
      • Construct alignments
      • Construct design tool
      • Experiment browser
    • Truncation/Fusion analysis
      • Truncation sites
      • Fusion sites
      • Loop deletions
    • Mutation analysis
      • Stabilising mutations
      • StabMutAnalyser
      • Mutation substitution matrix
    • DETERMINANTS & MUTATIONS
    • Sequence signature tool
    • State stabilizing mutation design
  • Drugs & ligands
    • LIGANDS & BIOACTIVITIES
    • Ligand coverage
    • Ligands (ChEMBL, GtP, Ki db)
      • Ligands (by receptor query)
      • Ligands (by ligand query)
    • PHYSIOLOGICAL LIGANDS
    • Physiological ligands (GtP)
    • DRUGS & AGENTS IN TRIAL
    • Agents/drugs
      • Agent/drug page
      • Agents/drugs by phase I-IV
    • Targets
      • Target page
      • Targets by phase I-IV
      • The drugged GPCRome
      • Target selection tool
    • Diseases
      • Disease page
      • Disease overview
    • LIGAND SITES
    • GPCR-ligand interactions
    • Site search
      • Site search (by seq. motif)               
      • Site search (by ligand complex)
    • LIGAND SITE MUTATIONS
    • Mutation coverage
    • Mutations
    • Mutation design tool
      • By receptor name
      • By PDB id
    • Mutation data submission
  • GproteinDb
    • Citing GproteinDb
    • G protein page
    • COUPLINGS
    • Couplings
    • Datasets
    • Biosensors
    • COUPLING ANALYSIS
    • Coupling selectivity (tree)
    • Coupling selectivity (Venn)
    • SEQUENCES
    • Sequence alignments
    • Generic residue number tables
    • STRUCTURES
    • Structure coverage
    • Structures
    • Structure models
    • STRUCTURE ANALYSIS
    • Interface interactions & profiling
    • Structure superposition
    • DETERMINANTS & MUTATIONS
    • Coupling determinant mutation design
    • Interface mutations & chimeras
  • ArrestinDb
    • Citing ArrestinDb
    • Arrestin page
    • COUPLINGS
    • Couplings
    • COUPLING ANALYSIS
    • Coupling selectivity (tree)
    • Coupling selectivity (Venn)
    • SEQUENCES
    • Sequence alignments
    • Generic residue number tables
    • STRUCTURES
    • Structure coverage
    • Structures
    • STRUCTURE ANALYSIS
    • Interface interactions (single structure)
    • DETERMINANTS & MUTATIONS
    • Interface mutations
  • Biased Signaling Atlas
    • Citing Biased Signaling Atlas
    • GUIDELINES
    • Community guidelines paper
    • Reference ligand selection
    • Template to calculate ligand bias factors
    • BIASED LIGANDS (for transducer family)
    • Biased ligand coverage
    • Biased ligands
    • Ligand bias rank orders
    • Ligand pathway profiles (Δlog(Emax/EC50))
    • Ligand pathway profiles (Δlog(Tau/KA))
    • BIASED LIGANDS (for transducer subtype)
    • Biased ligand coverage
    • Biased ligands
    • Ligand bias rank orders
    • Ligand pathway profiles (Δlog(Emax/EC50))
    • Ligand pathway profiles (Δlog(Tau/KA))
    • PATHWAY-PREFERRING LIGANDS (for transducer family)
    • Pathway-preferring ligand coverage
    • Pathway-preferring ligands (pathway ∆Log/(Emax/EC50)
    • Ligand pathway preference rank orders (Δlog(Emax/EC50))
    • Ligand pathway profiles (Log(Emax/EC50))
    • Pathways
    • Pathway effects
    • DATA DEPOSITION
    • Data submission
  • Join us
    • Data annotation
    • Database development
    • Scientific collaboration
    • Social media
    • Give feedback

Join us

Cite us

Main reference

  • -- select page --

      • Please cite the main reference and the reference for the page that you are using.

    • Select
      Target Indication Agent/Drug
      Gene Protein Receptor family Ligand type Class Indication name ICD11 ATC Association score Phase Approved